Aurobindo Pharma: To buy some operations, 3 US units from Sandoz for $900 mn
AurobindoPharma: To become 2nd largest generic player in US on Deal with Sandoz to add 300 products in US
Other News Videos
'Tough times never last, tough nations do': Ambani seeks fresh RIL momentum after Rs 1.5 lakh cr...
$320 billion danger: Why 70 EM funds still remain underweight on India
RIL AGM 2026: Date, Time & 4 Big Things to Watch (Jio IPO, Retail, Energy)
SpaceX IPO LIVE | Elon Musk becomes world's first trillionaire as company makes historic debut
SEBI unveils Pilot DLT tokenisation project as risk evaluation process continues